

EXOSOMM is the first and only company in the world to produce *active milk exosomes* at *industrial scale*, with a shelf life exceeding one year.
Our proprietary, patent-protected process sustainably isolates exosomes from cow milk whey—a dairy side-stream—without the use of chemicals, transforming waste into high-value therapeutic solutions for inflammatory diseases
What Are Milk Exosomes?
Exosomes are nano-sized vesicles that carry microRNAs, proteins, and lipids, acting as messengers for cellular communication. In milk, these exosomes are naturally bioavailable, surviving digestion and delivering bioactive signals that support immune regulation, gut health, and systemic anti-inflammatory responses.


Unlocking the Power of Milk Exosomes—At Scale
EXOSOMM is the first and only company to produce bioactive milk exosomes at an industrial scale, with long shelf life—a breakthrough no one else has achieved. Our proprietary process preserves the structural integrity and biological function of milk exosomes, making their therapeutic potential finally accessible for commercial use.
For years, the complexity of isolating milk exosomes without compromising their bioactivity has kept them out of reach. EXOSOMM changes that.
This unparalleled capacity, combined with the exceptional stability and long shelf-life of our powdered formulation, ensures a consistent and accessible supply chain, enabling broad market penetration across diverse applications.
• Consistent supply for large-scale manufacturing
• Reduced logistics and storage costs
• Global distribution capabilities
• Accelerated product development for partners